Pleuroparenchymal fibroelastosis: one more walk on the wild side of drugs?

Affiliations

¹ Dept of Pulmonary Medicine and Intensive Care, Centre Hospitalier Universitaire Le Bocage, Dijon, France Faculté de Médecine, Université de Bourgogne, Dijon, France ph.camus@chu-dijon.fr.
² Dept of Pathology, Medisch Centrum Haaglanden, Den Haag, The Netherlands.
³ Dept of Thoracic Imaging, National Heart and Lung Institute, Imperial College London, Royal Brompton and Harefield NHS Foundation Trust, London, UK.
⁴ Dept of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ, USA.

Free article

Editorial

Philippe Camus et al. Eur Respir J. 2014 Aug.

Free article

. 2014 Aug;44(2):289-96.

doi: 10.1183/09031936.00088414.

¹ Dept of Pulmonary Medicine and Intensive Care, Centre Hospitalier Universitaire Le Bocage, Dijon, France Faculté de Médecine, Université de Bourgogne, Dijon, France ph.camus@chu-dijon.fr.
² Dept of Pathology, Medisch Centrum Haaglanden, Den Haag, The Netherlands.
³ Dept of Thoracic Imaging, National Heart and Lung Institute, Imperial College London, Royal Brompton and Harefield NHS Foundation Trust, London, UK.
⁴ Dept of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ, USA.

No abstract available

Comment on

Pleuroparenchymal fibroelastosis as a late complication of chemotherapy agents.
Beynat-Mouterde C, Beltramo G, Lezmi G, Pernet D, Camus C, Fanton A, Foucher P, Cottin V, Bonniaud P. Beynat-Mouterde C, et al. Eur Respir J. 2014 Aug;44(2):523-7. doi: 10.1183/09031936.00214713. Epub 2014 May 2. Eur Respir J. 2014. PMID: 24791830 No abstract available.